Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

New therapies are being developed that target integrin pathways to treat various diseases.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Stem-cell therapy shows promise for skin conditions but needs more research.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

New regenerative treatments for hair loss show promise but need more research for confirmation.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

New treatments for skin and hair repair show promise, but further improvements are needed.

Cetuximab can cause eyelash growth, which is rare but manageable.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Many research paper titles in dermatology journals lack scientific precision.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Adding yeast extract and methyl jasmonate to Eclipta alba cell cultures increased the production of the compound wedelolactone.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Finasteride works best in 6 months and lasts 6 years.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.